908 Devices (MASS) Cash from Investing Activities (2020 - 2026)
908 Devices' (MASS) quarterly Cash from Investing Activities came in at -$2.0 million in Q1 2026, down 103.96% year-on-year from $50.3 million in Q1 2025, and down 129.24% on a QoQ basis from $6.8 million in Q4 2025.
908 Devices (MASS) Cash from Investing Activities (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Cash from Investing Activities data on file, last reported at -$2.0 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 103.96% year-over-year to -$2.0 million in Q1 2026; TTM through Mar 2026 was -$1.6 million, a 115.93% decrease from a year earlier, with the FY2025 full-year figure at $50.7 million, up 209.56% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$2.0 million, down from $6.8 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for MASS reached as high as $50.3 million in Q1 2025 and fell as low as -$45.1 million in Q2 2024.
- Historically, Cash from Investing Activities has averaged -$2.3 million across 5 years, with a median of -$617000.0 in 2022.
- Across the five-year window, Cash from Investing Activities plunged 27588.89% in 2023 and jumped 970.47% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$612000.0 in 2022, then soared by 857.52% to $4.6 million in 2023, then slumped by 83.18% to $780000.0 in 2024, then surged by 773.08% to $6.8 million in 2025, then sank by 129.24% to -$2.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$2.0 million in Q1 2026, $6.8 million in Q4 2025, and $5.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | 908 Devices | 264.17 Mn | 152.43 Mn | 6.88 Mn | -1.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.99 Mn |
| Mar 31, 2026 | -1.99 Mn |
| Dec 31, 2025 | 6.81 Mn |
| Dec 31, 2025 | 6.81 Mn |
| Sep 30, 2025 | 5.21 Mn |
| Sep 30, 2025 | 5.21 Mn |
| Jun 30, 2025 | -11.59 Mn |
| Jun 30, 2025 | -11.59 Mn |
| Mar 31, 2025 | 50.31 Mn |
| Mar 31, 2025 | 50.31 Mn |
| Dec 31, 2024 | 780,000.00 |
| Dec 31, 2024 | 780,000.00 |
| Sep 30, 2024 | 3.79 Mn |
| Sep 30, 2024 | 3.79 Mn |
| Jun 30, 2024 | -45.11 Mn |
| Jun 30, 2024 | -45.11 Mn |
| Mar 31, 2024 | -5.78 Mn |
| Mar 31, 2024 | -5.78 Mn |
| Dec 31, 2023 | 4.64 Mn |
| Dec 31, 2023 | 4.64 Mn |